Good he was overpaid, anyway. $250k is way to much for a junior tech company. Especially one that is focused on Korea. Young Yu probably doing all the hard yards anyway.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025